The SEC filings say DR-70 and CIT are failures.
DR-70: marketed since 1996, revenues have always been poor. There is no reason to think they will ever be anything else.
CIT: In their last 10-K, Radient declared CIT to have zero value and said it was not worth developing. They took a full write-off.
How would Radient "pare down" the existing debt? Interest has been accruing at 24% since Radient defaulted on the loans in early 2011. In addition, Radient disclosed in December 2011 that they were $900,000 behind in operational bills, and would have to cease operations, which they did in January 2012.
Radient did not have money to maintain FDA approval of onko-sure. They did not have enough money to pay insurance for the officers, who left. Even Boswell left. They haven't paid for a PR in how long?
Please provide your evidence that there are "interested parties." Thanks in advance.
